Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
16.80
-0.44 (-2.55%)
At close: Mar 6, 2026, 4:00 PM EST
16.99
+0.19 (1.13%)
After-hours: Mar 6, 2026, 4:31 PM EST
Eton Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Revenue | 70.32 | 39.01 | 31.64 | 21.25 | 21.83 | 0.04 | Upgrade
|
| Revenue Growth (YoY) | 102.77% | 23.29% | 48.90% | -2.66% | 55879.49% | -95.93% | Upgrade
|
| Cost of Revenue | 30.53 | 15.6 | 10.58 | 6.93 | 2.83 | 0.44 | Upgrade
|
| Gross Profit | 39.79 | 23.41 | 21.06 | 14.32 | 19.01 | -0.4 | Upgrade
|
| Selling, General & Admin | 33.27 | 22.34 | 18.93 | 18.58 | 14.27 | 12.67 | Upgrade
|
| Research & Development | 5.11 | 3.26 | 3.32 | 4 | 6.23 | 14.05 | Upgrade
|
| Operating Expenses | 38.38 | 25.59 | 22.25 | 22.58 | 20.5 | 26.71 | Upgrade
|
| Operating Income | 1.41 | -2.18 | -1.19 | -8.26 | -1.5 | -27.11 | Upgrade
|
| Interest Expense | -4.91 | -2.01 | -1.06 | -0.96 | -1.04 | -0.88 | Upgrade
|
| Interest & Investment Income | 1.1 | 0.79 | 1.56 | 0.19 | 0.04 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | -2.4 | -3.39 | -0.69 | -9.02 | -2.5 | -27.97 | Upgrade
|
| Merger & Restructuring Charges | -4.09 | -0.42 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.18 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.37 | - | Upgrade
|
| Pretax Income | -6.48 | -3.81 | -0.69 | -9.02 | -1.96 | -27.97 | Upgrade
|
| Income Tax Expense | 0.2 | 0.02 | 0.25 | - | - | - | Upgrade
|
| Net Income | -6.68 | -3.82 | -0.94 | -9.02 | -1.96 | -27.97 | Upgrade
|
| Net Income to Common | -6.68 | -3.82 | -0.94 | -9.02 | -1.96 | -27.97 | Upgrade
|
| Shares Outstanding (Basic) | 27 | 26 | 26 | 25 | 25 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 26 | 26 | 25 | 25 | 21 | Upgrade
|
| Shares Change (YoY) | 3.52% | 0.97% | 1.99% | -0.24% | 19.98% | 18.30% | Upgrade
|
| EPS (Basic) | -0.25 | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 | Upgrade
|
| EPS (Diluted) | -0.26 | -0.15 | -0.04 | -0.36 | -0.08 | -1.33 | Upgrade
|
| Free Cash Flow | 21.01 | 0.94 | 6.82 | 4.78 | -4.73 | -22.4 | Upgrade
|
| Free Cash Flow Per Share | 0.79 | 0.04 | 0.27 | 0.19 | -0.19 | -1.07 | Upgrade
|
| Gross Margin | 56.59% | 60.01% | 66.56% | 67.38% | 87.05% | - | Upgrade
|
| Operating Margin | 2.00% | -5.59% | -3.77% | -38.87% | -6.85% | -69515.39% | Upgrade
|
| Profit Margin | -9.50% | -9.80% | -2.96% | -42.45% | -8.96% | -71717.95% | Upgrade
|
| Free Cash Flow Margin | 29.89% | 2.42% | 21.54% | 22.51% | -21.66% | -57425.64% | Upgrade
|
| EBITDA | 4.72 | -1.11 | -0.36 | -6.55 | -1.12 | -26.59 | Upgrade
|
| EBITDA Margin | 6.71% | -2.83% | -1.13% | -30.81% | -5.13% | - | Upgrade
|
| D&A For EBITDA | 3.31 | 1.08 | 0.83 | 1.71 | 0.37 | 0.52 | Upgrade
|
| EBIT | 1.41 | -2.18 | -1.19 | -8.26 | -1.5 | -27.11 | Upgrade
|
| EBIT Margin | 2.00% | -5.59% | -3.77% | -38.87% | -6.85% | - | Upgrade
|
| Revenue as Reported | 70.32 | 39.01 | 31.64 | 21.25 | 21.83 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.